This website uses cookies to enhance the user experience.
||
UNI TARGETING RESEARCH AS

UNI TARGETING RESEARCH AS983 422 748

Limited company
c/o Dagfinn Øgreid Bolignummer H0504 Storgata 61 4307 SANDNES, Norge

UNI TARGETING RESEARCH AS

Uni Targeting Research
UniTargetingResearch AS is a biotech spin-of of the University of Bergen, Norway, Newcastle University, UK, and University of Barcelona, Spain.,UniTargetingResearch AS is a biotech spin-of of the University of Bergen, Norway, Newcastle University, UK, and University of Barcelona, Spain.

Links

Organization

Chairman of the board
Years since formation
24 years
since Jun 11, 2001
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
426,526,343
1 share class
Total number of shareholders
16
9 companies, 7 persons
Belongs to group of

Financials

Total operating income 2024
3,714,280
NOK
Annual total result 2024
-5,063,814
NOK
Total equity 2024
3,055,021
NOK
Last update: Sep 16, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
31.3 %
indirectly

Board

NameRoleShares
Chairman
31.3 %
indirectly
Board Member
31.3 %
indirectly
ResignedBoard Member
8.22 %
indirectly

Others

NameRoleShares
R
REVISOR-PARTNER AS
Auditor-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
31.3 %
indirectly
Board Member
31.3 %
indirectly
-
8.22 %
indirectly
Board Member
8.22 %
indirectly
-
8.22 %
indirectly
-
8.22 %
indirectly
-
1.23 %
indirectly
Last update: Nov 6, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
C
COLOALERT AS
Ordinary shares
144,628,099
33.91 %
H
HANNIBAL INVEST AS
Ordinary shares
91,975,099
21.56 %
R
ROLOGEN AS
Ordinary shares
85,274,242
19.99 %
C
CITRON AS
Ordinary shares
85,274,242
19.99 %
Ordinary shares
7,200,000
1.69 %
L
LUCY AS
Ordinary shares
5,229,651
1.23 %
U
UNI TARGETING RESEARCH AS
Ordinary shares
2,136,738
0.5 %
C
CAABY AS
Ordinary shares
1,538,132
0.36 %
E
ENG AS
Ordinary shares
1,276,595
0.3 %
F
FINYIELD AS
Ordinary shares
922,879
0.22 %
Ordinary shares
489,333
0.11 %
Ordinary shares
379,333
0.09 %
Ordinary shares
150,000
0.04 %
Ordinary shares
20,000
< 0.01 %
Ordinary shares
16,000
< 0.01 %
Ordinary shares
16,000
< 0.01 %

Shares owned by the UNI TARGETING RESEARCH AS

NameShare classTotal number of sharesShare
E
EUROPEAN ONCOLOGY LAB AS
Ordinary shares
30,000
100 %
U
UNI TARGETING RESEARCH AS
Ordinary shares
2,136,738
0.5 %
Last update: Jun 2, 2025

Group structure

Financials

in NOK

Summary

Year2024202320222021
Total operating income
3,714,280
19,212,741
4,506,049
1,528,823
Annual Total Result
-5,063,814
16,802,933
1,727,160
-1,267,826
Total assets
8,165,328
28,180,972
6,418,184
900,577
Total liabilities
5,110,308
5,333,282
373,425
1,592,068
Total equity
3,055,021
22,847,691
6,044,758
-691,491

P&L

Year2024202320222021
Total operating income
3,714,280
19,212,741
4,506,049
1,528,823
Total operating costs
3,151,339
2,823,237
2,721,059
2,951,780
Operating result
562,941
16,389,504
1,784,990
-1,422,957
Financial income/costs
-5,626,755
413,429
-57,830
155,132
Profit before tax
-5,063,814
16,802,933
1,727,160
-1,267,826
Total tax & extraordinary income/cost
0
0
0
0
Annual Total Result
-5,063,814
16,802,933
1,727,160
-1,267,826

Balance overview

Year2024202320222021
Total fixed assets
6,657,692
58,166
4,875,840
0
Total current assets
1,507,636
28,122,806
1,542,344
900,577
Total assets
8,165,328
28,180,972
6,418,184
900,577
Short term debt
5,110,308
5,333,282
373,425
1,592,068
Long term debt
0
0
0
0
Total liabilities
5,110,308
5,333,282
373,425
1,592,068
Contributed capital
7,072,051
7,058,008
7,095,554
2,086,465
Retained earnings
-4,017,030
15,789,683
-1,050,796
-2,777,957
Total equity
3,055,021
22,847,691
6,044,758
-691,491
Total equity and liabilities
8,165,329
28,180,973
6,418,184
900,577

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises